Alzheimer Disease Detection System using AlexNet a novel Eight Layered Convolutional Neural Network

Alzheimer's disease (AD), an incurable brain ailment that is irreversible, affects thinking and memory while also shrinking the size of the mind as a whole. Alzheimer's is a neurological illness that causes severe memory loss and makes it difficult to carry out regular chores. The development of more effective treatments for AD depends on an early diagnosis of the condition. Finding Alzheimer's disease is a difficult and time-consuming task that requires a brain imaging report and competent people. This time-consuming and frequently inaccurate method of diagnosing Alzheimer's is traditional. There has been discussion of a different strategy that is quick, inexpensive, and more dependable. Better medical care and solutions can be provided with the use of artificial intelligence technologies. Due to distractions, technological flaws, cognitive biases, and weariness, human diagnosis performance suffers. However, AI-based diagnosis tools support physicians' safe detection and decision-making and are less prone to error. This study offers a clever and trustworthy method for identifying Alzheimer's disease and its potential early stage, moderate mental impairment. The given system accurately diagnoses Alzheimer's disease and its early stages from structural MRI images and is based on deep learning. The ability to predict whether patients with moderate cognitive impairment (MCI) may develop Alzheimer's disease is essential in clinical practice and has the potential to significantly improve clinical studies. To classify Alzheimer's disease and its prodromal stages, this initiative suggests combining MRI data with the Mini-Mental State Examination (MMSE), a neuropsychological test.